Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center

被引:36
作者
Hatakeyama, Shingo [1 ]
Yoneyama, Takahiro [1 ]
Hamano, Itsuto [1 ]
Murasawa, Hiromi [1 ]
Narita, Takuma [1 ]
Oikawa, Masaaki [1 ]
Hagiwara, Kazuhisa [1 ]
Noro, Daisuke [1 ]
Tanaka, Toshikazu [1 ]
Tanaka, Yoshimi [1 ]
Hashimoto, Yasuhiro [2 ]
Koie, Takuya [1 ]
Ohyama, Chikara [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Grad Sch Med, Dept Adv Transplant & Regenerat Med, Hirosaki, Aomori 0368562, Japan
来源
BMC UROLOGY | 2013年 / 13卷
基金
日本学术振兴会;
关键词
Renal cell carcinoma; Radical nephrectomy with thrombectomy; Tumor thrombus; Prognostic factors; TUMOR THROMBUS; EXTENSION; NEPHRECTOMY; INVOLVEMENT; SURGERY; IMPACT;
D O I
10.1186/1471-2490-13-47
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Management of renal cell carcinoma (RCC) with tumor thrombus extending to the renal vein and inferior vena cava (IVC) is challenging. The aim of this study was to evaluate the benefit of surgical management in such patients. Methods: From February 1995 to February 2013, 520 patients were treated for RCC at Hirosaki University Hospital, Hirosaki, Japan. The RCC patients with tumor thrombus extending to the renal vein (n = 42) and IVC (n = 43) were included in this study. The records of these 85 patients were retrospectively reviewed to assess the relevant clinical and pathological variables and survival. Prognostic factors were identified by multivariate analysis. The benefit of surgical management was evaluated using propensity score matching to compare overall survival between patients who received surgical management and those who did not. Results: RCC was confirmed by pathological examination of surgical or biopsy specimens in 74 of the 85 patients (87%). Sixty-five patients (76%) received surgical management (radical nephrectomy with thrombectomy). Distant metastasis was identified in 45 patients (53%). The proportion of patients with tumor thrombus level 0 (renal vein only), I, II, III, and IV was 49%, 13%, 18%, 14%, and 5%, respectively. The estimated 5-year overall survival rate was 70% in patients with thrombus extending to the renal vein and 23% in patients with thrombus extending to the IVC. Multivariate analysis identified thrombus extending to the IVC, presence of distant metastasis, surgical management, serum albumin concentration, serum choline esterase concentration, neutrophil-lymphocyte ratio, and Carlson comorbidity index as independent prognostic factors. In propensity score-matched patients, overall survival was significantly longer in those who received surgical management than those who did not. Conclusions: Surgical management may improve the prognosis of RCC patients with thrombus extending to the renal vein and IVC.
引用
收藏
页数:11
相关论文
共 26 条
  • [1] Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome
    Al Otaibi, Mohammed
    Youssif, Tamer Abou
    Alkhaldi, Abdulaziz
    Sircar, Kanishka
    Kassouf, Wassim
    Aprikian, Armen
    Mulder, David
    Tanguay, Simon
    [J]. BJU INTERNATIONAL, 2009, 104 (10) : 1467 - 1470
  • [2] [Anonymous], 2010, International Union against Cancer. TNM classification of malignant tumours
  • [3] [Anonymous], 2015, AJCC Cancer Staging Manual
  • [4] Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis
    Bainbridge, Daniel
    Martin, Janet
    Arango, Miguel
    Cheng, Davy
    [J]. LANCET, 2012, 380 (9847) : 1075 - 1081
  • [5] Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib
    Bex, Axel
    Van der Veldt, Astrid A. M.
    Blank, Christian
    Meijerink, Martijn R.
    Boven, Epie
    Haanen, John B. A. G.
    [J]. ACTA ONCOLOGICA, 2010, 49 (04) : 520 - U124
  • [6] The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus
    Blute, ML
    Leibovich, BC
    Lohse, CM
    Cheville, JC
    Zincke, H
    [J]. BJU INTERNATIONAL, 2004, 94 (01) : 33 - 41
  • [7] The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus
    Cost, Nicholas G.
    Delacroix, Scott E., Jr.
    Sleeper, Joshua P.
    Smith, Paul J.
    Youssef, Ramy F.
    Chapin, Brian F.
    Karam, Jose A.
    Culp, Stephen
    Abel, E. Jason
    Brugarolas, James
    Raj, Ganesh V.
    Sagalowsky, Arthur I.
    Wood, Christopher G.
    Margulis, Vitaly
    [J]. EUROPEAN UROLOGY, 2011, 59 (06) : 912 - 918
  • [8] Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension
    Gettman, MT
    Boelter, CW
    Cheville, JC
    Zincke, H
    Bryant, SC
    Blute, ML
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04) : 1282 - 1286
  • [9] Renal cell carcinoma with tumor thrombus extension into the vena cava:: Prospective long-term followup
    Haferkamp, Axel
    Bastian, Patrick J.
    Jakobi, Hildegard
    Pritsch, Maria
    Pfitzenmaier, Jesco
    Albers, Peter
    Hallscheidt, Peter
    Mueller, Stefan C.
    Hohenfellner, Markus
    [J]. JOURNAL OF UROLOGY, 2007, 177 (05) : 1703 - 1708
  • [10] Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib
    Harshman, Lauren C.
    Srinivas, Sandy
    Kamaya, Aya
    Chung, Benjamin I.
    [J]. NATURE REVIEWS UROLOGY, 2009, 6 (06) : 338 - 343